Skip to main content
OpenTrials
Completed

NCT Number: NCT00555191

Fructose Malabsorption in Northern Norway

Different published studies has shown a possible co-variation between leakage of fructose to the great bowel and exacerbation of irritable bowel syndrome (IBS) symptoms.

The aim of the FINN trial is to study the role of fructose malabsorption in patients with IBS in order to evaluate different diagnostic criteria for fructose malabsorption and at the same time study the effect of diet treatment in this cohort of patients and estimate the prevalence of fructose malabsorption.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Irritable Bowel Syndrome Carbohydrate Metabolism, Inborn Errors Colonic Diseases Colonic Diseases, Functional Congenital, Hereditary, and Neonatal Diseases and Abnormalities Digestive System Diseases Fructose Intolerance Fructose Malabsorption Fructose Metabolism, Inborn Errors Gastrointestinal Diseases Genetic Diseases, Inborn Intestinal Diseases Malabsorption Syndromes Metabolic Diseases Metabolism, Inborn Errors Nutritional and Metabolic Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 2 / Phase 3

Primary location

Hospital of Rana Medical Dep. Helgelandsykehuset HF

Mo i Rana, Nordland, 8607, Norway

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • IBS patients satisfying ROME 2 diagnostic criteria

Exclusion criteria

  • Seriously ill
  • Organic abdominal disease
  • Other functional bowel disease

Treatment and study plan

diet restriction

Behavioral

each meal should contain less than 2 gm fructose

Primary outcomes

  1. VAS score og specific abdominal complaints.SGA score of relief related to abdominal complaints.

    Time frame: 12 weeks

Secondary outcomes

  1. Estimate sensitivity,specificity,negative and positive predictive value using 50 gm fructose in breath test.Validate questionary for intolerance.Validate VAS in judging changes in abdominal complaint.Examine polymorphism i Glut5 transporter gene.

    Time frame: 12 weeks

Sponsors and collaborators

Lead sponsor

University Hospital of North Norway

Other

Collaborators

  • Nordlandssykehuset HF

Registry information

Official study title

Fructose Malabsorption in Northern Norway. Fructose Malabsorption and Irritable Bowel Syndrome.

Acronym: FINN

Important dates

Study start
2007
Primary completion
2016
Study completion
2016
First posted
Nov 8, 2007
Registry last updated
May 24, 2016

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.